Avoro Capital Advisors LLC

Holdings History for Corvus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (CRVS)

Symbol: CRVS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2017		-0.32%	$0	0	-121,715	-100%	$19.74	Q2 2017
31 Mar 2017	0.32%	-0.25%	$2,528,000	121,715	-94,904	-44%	$20.77	Q1 2017
31 Dec 2016	0.63%	-0.15%	$3,098,000	216,619	-51,750	-19%	$14.30	Q4 2016
30 Sep 2016	0.78%	+0.57%	$4,415,000	268,369	+193,569	+259%	$16.45	Q3 2016
30 Jun 2016	0.24%	0%	$1,067,000	74,800	0		$14.26	Q2 2016
31 Mar 2016	0.38%	+0.38%	$1,085,000	74,800	+74,800	NEW	$14.51	Q1 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.